A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Inhaled CVT-301 (Levodopa Inhalation Powder) in Parkinson’s Disease Patients With Motor Response Fluctuations (OFF Phenomena)

Principal Investigator: Brad Racette, MD